Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,171 | 26,024 | 57,536 | 56,357 | 193,650 |
| Marketable Securities | 157,338 | 168,086 | 123,322 | 148,145 | N/A |
| Receivables | 3,432 | 2,419 | 1,903 | 1,090 | 35,986 |
| TOTAL | $182,936 | $201,204 | $187,801 | $212,277 | $237,102 |
| Non-Current Assets | |||||
| PPE Net | 3,958 | 4,060 | 4,499 | 4,573 | 5,072 |
| Intangibles | 1,678 | 1,715 | 1,751 | 1,788 | 1,824 |
| Other Non-Current Assets | 13,220 | 14,188 | 15,134 | 15,992 | 16,893 |
| TOTAL | $18,856 | $19,963 | $21,384 | $22,353 | $23,789 |
| Total Assets | $201,792 | $221,167 | $209,185 | $234,630 | $260,891 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 4,082 |
| Accounts payable and accrued liabilities | 1,458 | 1,705 | 1,029 | 2,203 | 2,809 |
| Accrued Expenses | 17,599 | 20,689 | 20,068 | 22,275 | 24,450 |
| TOTAL | $155,913 | $146,790 | $141,377 | $151,262 | $152,608 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 132,267 | 124,396 | 120,280 | 126,784 | 121,267 |
| Other Non-Current Liabilities | 13,278 | 13,354 | 11,962 | 12,872 | 13,975 |
| TOTAL | $93,326 | $125,615 | $152,835 | $170,005 | $194,034 |
| Total Liabilities | $249,239 | $272,405 | $294,212 | $321,267 | $346,642 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,722 | 66,989 | 66,768 | 66,339 | 66,228 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -723,448 | -724,285 | -727,277 | -726,190 | -722,879 |
| Other shareholders' equity | 95 | -63 | 35 | 26 | 10 |
| TOTAL | $-47,447 | $-51,238 | $-85,027 | $-86,637 | $-85,751 |
| Total Liabilities And Equity | $201,792 | $221,167 | $209,185 | $234,630 | $260,891 |